novo nordisk new glp 1 Novo, Lilly buoyed by fast-growing GLP-1 drug sales Novo Nordisk Finds Medicare Patients

Welchol should not be taken if you have stomach or intestinal problems, including gastroparesis (when the stomach takes too long to empty its contents), abnormal contractions of the digestive system, a history of major gastrointestinal tract surgery, if you have trouble swallowing, by those who might be at risk for intestinal blockage, or if you have vitamin A, D, E, or K deficiencies

Are you on a GLP-1

Thats biology, not a personal failure

And the percentages you just stated were the mean or average weight losses in the trials: 15%, 20%

Meto treats obesity, insulin resistance, PCOS, perimenopause, thyroid disorders, and metabolic syndrome as interconnected conditions rather than separate silos

10.2337/db16-0755 264